APA (7th ed.) Citation

Pabinger, I., Jain, N., Winding, B., Tsao, E., Liesner, R., Pasi, K. J., . . . Brown, S. A. (2016). Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a. Blood, 128, 3791. https://doi.org/10.1182/blood.v128.22.3791.3791

Chicago Style (17th ed.) Citation

Pabinger, Ingrid, et al. "Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a." Blood 128 (2016): 3791. https://doi.org/10.1182/blood.v128.22.3791.3791.

MLA (9th ed.) Citation

Pabinger, Ingrid, et al. "Long-Term Efficacy and Quality of Life with Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) Prophylaxis in Pediatric, Adolescent, and Adult Subjects with Target Joints and Severe Hemophilia a." Blood, vol. 128, 2016, p. 3791, https://doi.org/10.1182/blood.v128.22.3791.3791.